Michael P Blair to Retrospective Studies
This is a "connection" page, showing publications Michael P Blair has written about Retrospective Studies.
Connection Strength
0.842
-
Laser Prophylaxis in Patients with Stickler Syndrome. Ophthalmol Retina. 2022 04; 6(4):263-267.
Score: 0.079
-
Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705.
Score: 0.074
-
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
Score: 0.071
-
Efficacy of Retinal Lesion Screening in Von Hippel-Lindau Patients With Widefield Color Fundus Imaging Versus Widefield FA. Ophthalmic Surg Lasers Imaging Retina. 2019 11 01; 50(11):e260-e265.
Score: 0.069
-
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
Score: 0.067
-
Macular optical coherence tomography in patients with unilateral optic nerve hypoplasia. J AAPOS. 2015 Feb; 19(1):57-61.
Score: 0.049
-
Peripheral retinal nonperfusion in fellow eyes in coats disease. Retina. 2013 Sep; 33(8):1694-9.
Score: 0.045
-
Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children. J AAPOS. 2012 Jun; 16(3):234-7.
Score: 0.041
-
Transconjunctival 20-gauge vitrectomy outcomes. Ophthalmic Surg Lasers Imaging. 2011 Jul-Aug; 42(4):278-83.
Score: 0.039
-
Effects of green diode laser in the treatment of pediatric Coats disease. Am J Ophthalmol. 2011 Apr; 151(4):725-731.e2.
Score: 0.037
-
Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina. 2010 Jan; 30(1):140-5.
Score: 0.035
-
Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin. Retina. 2004 Aug; 24(4):501-6.
Score: 0.024
-
Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infants. J AAPOS. 2023 02; 27(1):12.e1-12.e7.
Score: 0.021
-
Late Vitreoretinal Complications of Regressed Retinopathy of Prematurity: Retinal Break, Vitreous Hemorrhage, and Retinal Detachment. Ophthalmol Retina. 2023 01; 7(1):72-80.
Score: 0.021
-
Traumatic Retinal Detachment in Patients with Self-Injurious Behavior: An International Multicenter Study. Ophthalmol Retina. 2021 08; 5(8):805-814.
Score: 0.018
-
Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
Score: 0.018
-
Late-Onset Retinal Findings and Complications in Untreated Retinopathy of Prematurity. Ophthalmol Retina. 2020 06; 4(6):602-612.
Score: 0.017
-
FEVR phenotype associated with septo-optic dysplasia. Ophthalmic Genet. 2019 10; 40(5):449-452.
Score: 0.017
-
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
Score: 0.016
-
PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
Score: 0.015
-
Immediate Sequential Bilateral Pediatric Vitreoretinal Surgery: An International Multicenter Study. Ophthalmology. 2016 08; 123(8):1802-1808.
Score: 0.014
-
CONCURRENT SCLERAL BUCKLE AND INTRAVITREAL BEVACIZUMAB FOR ADVANCED RETINOPATHY OF PREMATURITY-RELATED RETINAL DETACHMENT. Retin Cases Brief Rep. 2016; 10(2):183-6.
Score: 0.013
-
Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis. Retin Cases Brief Rep. 2014; 8(1):24-9.
Score: 0.011
-
Peripheral nonperfusion and tractional retinal detachment associated with congenital optic nerve anomalies. Ophthalmology. 2013 Mar; 120(3):607-615.
Score: 0.011
-
Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012 Aug; 130(8):1000-6.
Score: 0.010
-
Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009 Oct; 25(5):453-8.
Score: 0.009